| Jun 30, 2014
| 7:04 PM
MannKind Corp., the Valencia company that last week won approval to market an inhalable form of insulin to people with diabetes, saw its shares climb 10% on Monday.
The Food and Drug Administration announced Friday that it had approved MannKind's drug,...
| Sep 9, 2014
| 12:09 PM
Botox maker Allergan Inc. of Irvine appears increasingly likely to be acquired by a Canadian rival, an analyst said Tuesday.
Valeant Pharmaceuticals International Inc. has been working for five months to acquire Allergan and its coveted lineup of beauty...
| Sep 6, 2014
| 3:16 PM
A white powdered chemical compound emerged from two University of Maryland School of Medicine laboratories more than 10 years ago with a name destined for oblivion, but a future that now looks promising as a treatment for the most challenging cases of...
| Sep 5, 2014
| 5:17 PM
A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs to combat diseases afflicting the elderly.
Half of the initial $500 million investment...
| Aug 31, 2014
| 6:34 PM
CytRx Corp. is on a mission to cure cancer — or at least slow it down.
The Los Angeles biopharmaceutical company, which recently has become embroiled in a stock-promotion controversy, specializes in researching and developing drugs to treat...
| Sep 2, 2014
| 9:37 PM
With the Ebola outbreak threatening to spiral out of control, U.S. officials unveiled a multimillion-dollar plan Tuesday aimed at getting a promising drug out of American research labs and into African hospitals and clinics more quickly.
| Sep 3, 2014
| 8:39 AM
Lake Forest-based drugmaker Hospira's talks to buy the medical nutrition unit of Danone and use the deal to move its tax domicile abroad have stalled, according to people familiar with the matter, as attempts by U.S. companies to relocate abroad and cut...
| Aug 26, 2014
| 3:45 PM
Allergan Inc. scheduled a Dec. 18 special meeting of its shareholders that could ultimately resolve a hostile takeover attempt by a Canadian rival.
Valeant Pharmaceuticals International Inc., which is based near Montreal, has been fighting since April...
| Aug 27, 2014
| 2:30 AM
Whether you get your prescription drugs through your employer's health plan or through a Medicare Part D plan, there are ways you can save on your medications.
Keep an eye out for new generic drugs. The patents for several popular brand-name drugs --...
| Aug 19, 2014
| 11:23 AM
With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
| Aug 21, 2014
Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth.
The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...